文献速递免疫规划卫生政策与健康促进

越南全国实施轮状病毒疫苗接种的影响与成本效果:模型研究

Impact and cost-effectiveness of national implementation of rotavirus vaccination in Vietnam: A modeling study.
PubMed 文献 · Vaccine · 2026-10-06

该建模研究评估越南全国接种国产ROTAVIN轮状病毒疫苗的影响与成本效果,比较2026年起十年内不接种与全国接种方案。结果显示接种可减少42%的轮状病毒胃肠炎疾病负担,避免97,776例住院和433例死亡,政府视角每避免一个DALY成本为982美元,社会视角具成本节约性。

要点

  • 全国接种ROTAVIN可减少42%的轮状病毒胃肠炎疾病负担,避免大量住院和死亡。
  • 政府视角每避免一个DALY成本为982美元,社会视角在基础情景下具成本节约性。
  • 在支付意愿阈值为越南人均GDP的0.5倍时,政府视角成本效果概率达99%。

核心结论

  • 全国接种ROTAVIN疫苗可大幅减轻越南轮状病毒疾病和经济负担,且具高度成本效果。

研究设计与样本

  • 采用透明静态队列模型,按周龄细分<5岁儿童,比较2026年起十年内不接种与全国接种国产ROTAVIN疫苗。
  • 模型输入来自全球、区域和本地数据,包括越南疫苗前发病率、本地疫苗效果和衰减数据及治疗成本。

主要发现

  • 十年内接种预计减少42%的轮状病毒胃肠炎健康负担,避免97,776例住院(95%不确定性区间72,722-342,311)和433例死亡(330-1300)。
  • 政府视角至少62%的接种成本可由医疗 savings 抵消;每避免一个DALY成本为982美元,社会视角基础情景下具成本节约性。

临床怎么用

  • 可为越南将轮状病毒疫苗纳入扩大免疫规划提供决策依据,尤其关注政府视角的成本效果阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Vietnam, rotavirus remains a leading cause of severe acute gastroenteritis resulting in hospitalization. Although rotavirus vaccines are available in the private sector-primarily accessible to urban children-the Expanded Programme on Immunization has only piloted the vaccine in select provinces. This study assessed the impact and cost-effectiveness of national rotavirus vaccination in Vietnam to inform policy decision on nationwide implementation. METHODS: We used a transparent static cohort model with a granular weekly age structure (< 5 years) to project rotavirus gastroenteritis (RVGE) cases, visits, hospitalizations, and deaths in children under five years, comparing no vaccination to nationwide vaccination with the domestic ROTAVIN vaccine over 10 years starting in 2026. Model inputs drew from global, regional, and local data including pre-vaccine incidence in Vietnam, local vaccine effectiveness and waning data, and treatment costs (governmental and societal perspectives) sourced from a local cost of illness study and hospital records (converted to 2025 USD). Deterministic and probabilistic sensitivity analyses addressed parameter uncertainty. RESULTS: Over ten years, ROTAVIN vaccination was projected to reduce RVGE health burden by 42%, averting 97,776 (95% uncertainty interval 72,722-342,311) hospital admissions and 433 (330-1300) deaths. The program would cost US$39.5 million ($30.7-$117.7 million) for ten birth cohorts (2026-2036). From the governmental perspective, at least 62% of vaccination costs would be offset by healthcare savings. The cost per DALY averted was estimated at $982 (governmental perspective), while the program was cost-saving from the societal perspective in the base case. Sensitivity analyses confirmed robustness, with a 99% probability of cost-effectiveness from the governmental perspective at a willingness-to-pay threshold of 0.5 times Vietnam's GDP per capita (and 100% from the societal perspective). CONCLUSIONS: Nationwide ROTAVIN vaccination could avert a substantial health and economic burden in Vietnam and would be highly cost-effective given recently published thresholds.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dang HTT, Clark A, Nguyen ALT, et al. Impact and cost-effectiveness of national implementation of rotavirus vaccination in Vietnam: A modeling study. Vaccine. 2026. PMID: 42837896. doi:10.1016/j.vaccine.2026.129220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。